Hamidi Alamdari Daryoush, Douzandeh Armina, Keshvari Shirvan Maliheh, Narouie Behzad, Radpour Negar
Vascular and Endovascular Surgery Research Center Mashhad University of Medical Sciences Mashhad Iran.
Department of Health and Biomedicine Victoria University Melbourne Victoria Australia.
Clin Case Rep. 2024 Mar 7;12(3):e8579. doi: 10.1002/ccr3.8579. eCollection 2024 Mar.
Innovative mixed treatment offers hope for persistent mixed urinary incontinence (MUI): PRP-Fibrin Glue-Stem Cell injection, Botox, and TVT in a single session. Successful case study reveals promising outcomes, emphasizing the need for further research.
Mixed urinary incontinence is a complaint of stress and urge incontinence which affects patients' quality of life and dramatic changes in patients' physical, mental, and socioeconomic status. The treatment is challenging and depends on the dominance of one of the complaints to the other. The progress in the method of treatment is still under discussion. This study reports treatment of a MUI case in a 56-year-old, with a history of MUI of 7-year duration, which was persistent to pharmacological treatment, pelvic muscle training, biofeedback, and anti-incontinence surgery (Burch Colposuspension). PRP-Fibrin Glue-Stem Cell injection, Botox injection, and TVT were performed in a one surgery session. Patient was discharged with ability to urinate with acceptable amount of post void residue. After 3-month follow-up, patient was completely satisfied and happy. Further research is needed to substantiate the efficacy of these mixed treatments for MUI.
创新的联合治疗为持续性混合性尿失禁(MUI)带来希望:在一次手术中进行富血小板血浆-纤维蛋白胶-干细胞注射、肉毒素注射和经阴道无张力尿道中段吊带术(TVT)。成功的病例研究显示了有前景的结果,强调了进一步研究的必要性。
混合性尿失禁是一种兼具压力性尿失禁和急迫性尿失禁的病症,会影响患者的生活质量,并使患者的身体、心理和社会经济状况发生巨大变化。其治疗具有挑战性,且取决于其中一种症状相对于另一种症状的主导程度。治疗方法的进展仍在讨论之中。本研究报告了一名56岁MUI患者的治疗情况,该患者有7年的MUI病史,对药物治疗、盆底肌训练、生物反馈以及抗尿失禁手术(Burch阴道悬吊术)均无效。在一次手术中进行了富血小板血浆-纤维蛋白胶-干细胞注射、肉毒素注射和TVT。患者出院时排尿能力良好,残余尿量可接受。经过3个月的随访,患者完全满意且心情愉悦。需要进一步研究来证实这些联合治疗对MUI的疗效。